AcelRx

pivot change turnaround direction walk away

Marketing

AcelRx becomes Talphera, adopting new name to reflect pain pivot

The biotech has shifted its focus to a pipeline led by a blood thinner and adopted a new name, Talphera, to reflect the revised strategy.

Nick Paul Taylor Jan 10, 2024 10:28am

FDAs OPDP warning letter to AcelRx banner attachments

FDA rebukes AcelRx for promo for potent opioid drug Dsuvia

Feb 18, 2021 8:50am

Scott Gottlieb FDA

FDA chief defends green light for AcelRx’s controversial opioid

Nov 5, 2018 11:45am